NCT05502146View on ClinicalTrials.gov

Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Spinal Anesthetic ToxicityHypotension Drug-InducedCesarean Section Complications
Interventions
DRUG

Noradrenaline Bitartrate

An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.

DRUG

Bupivacaine Hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

DRUG

Noradrenaline Bitartrate

An intravenous bolus of norepinephrine 8 mcg will be administered for management of maternal hypotension.

DRUG

Bupivacaine Hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

Trial Locations (1)

33343

Mersin University, Mersin

All Listed Sponsors
lead

Mersin University

OTHER